Bacterial Infections Clinical Trials

28 recruitingLast updated: June 18, 2026

There are 28 actively recruiting bacterial infections clinical trials across 28 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Paris, France, Suita, Osaka, Japan, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Bacterial Infections Trials at a Glance

28 actively recruiting trials for bacterial infections are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Paris, Suita, and Barcelona. Lead sponsors running bacterial infections studies include GramEye, Centre Hospitalier de Saint-Denis, and CanSino Biologics Inc..

Browse bacterial infections trials by phase

Treatments under study

About Bacterial Infections Clinical Trials

Looking for clinical trials for Bacterial Infections? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacterial Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacterial Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting
Phase 2

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Gram-Negative Bacterial Infections
Pfizer48 enrolled24 locationsNCT05639647
Recruiting

Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients

Bacterial Infections
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1,000 enrolled1 locationNCT07612163
Recruiting

Emergency PWAS in Respiratory Infectious Disease

Viral infectionsSepsisPneumonia+5 more
The University of Hong Kong2,000 enrolled1 locationNCT05336851
Recruiting

Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis

Bacterial InfectionsMeningitisViral Meningitis+1 more
Hospital Israelita Albert Einstein600 enrolled1 locationNCT07062445
Recruiting
Phase 3

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled62 locationsNCT05645107
Recruiting
Not Applicable

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

Patient ParticipationBacterial InfectionsInfective Endocarditis+1 more
Region Halland50 enrolled1 locationNCT06704048
Recruiting
Not Applicable

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

Severe Bacterial Infections
Nantes University Hospital1,401 enrolled6 locationsNCT07111793
Recruiting
Phase 3

A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Bacterial InfectionsPneumococcal InfectionsStreptococcal Infections
CanSino Biologics Inc.600 enrolled3 locationsNCT07017777
Recruiting
Phase 2

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 1

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

Bacterial Infections
University of Pennsylvania20 enrolled1 locationNCT04263792
Recruiting
Phase 2Phase 3

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Phase 1

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Bacterial Infections
Qpex Biopharma, Inc.40 enrolled2 locationsNCT07104162
Recruiting
Phase 1

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

Bacterial InfectionsRespiratory Tract InfectionsUrinary Tract Infections+1 more
Joincare Pharmaceutical Group Industry Co., Ltd66 enrolled1 locationNCT07207291
Recruiting

Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa

OsteomyelitisPseudomonas aeruginosaBacterial Infections+1 more
Centre Hospitalier de Saint-Denis300 enrolled1 locationNCT07056881
Recruiting
Phase 2

Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

Gram Negative PneumoniaGram-Negative Bacterial InfectionsBacteremia Caused by Gram-Negative Bacteria
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation234 enrolled2 locationsNCT06135350
Recruiting
Not Applicable

Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis

SepsisBacterial InfectionsCommunity-Acquired Infections+1 more
Ottawa Hospital Research Institute1,440 enrolled3 locationsNCT06103500
Recruiting

International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections

CirrhosisBacterial InfectionsMultidrug Resistance
Hospital Italiano de Buenos Aires1,000 enrolled1 locationNCT06634940
Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

OsteomyelitisEncephalitisSepsis+13 more
Infectopharm Arzneimittel GmbH1,000 enrolled50 locationsNCT02979951
Recruiting
Phase 4

Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY)

Bacterial InfectionsDecompensated Cirrhosis
Eva Bonfill198 enrolled1 locationNCT05783661
Recruiting
Not Applicable

Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy

Bacterial Infections
University Hospital, Toulouse296 enrolled7 locationsNCT05350813